Filgotinib for treating axial spondyloarthritis [ID6594]

  • In development
  • GID-TA11776
  • Expected publication date: TBC

Register as a stakeholder

To appraise the clinical and cost effectiveness of Filgotinib within its marketing authorisation for treating axial spondyloarthritis ID6594